Valuation : KPC Pharmaceuticals,Inc.

Market Cap 6.43B 957M 824M 775M 708M 1.32B 90.38B 1.33B 9.16B 3.55B 46.37B 3.59B 3.52B 149B P/E 2026 *
39.8x
P/E 2027 * 19x
Enterprise Value 6.43B 957M 824M 775M 708M 1.32B 90.38B 1.33B 9.16B 3.55B 46.37B 3.59B 3.52B 149B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.02x
Free-Float
60.48%
Yield 2026 *
-
Yield 2027 * -
1 day+0.47%
1 week-2.53%
Current month-0.93%
1 month-2.97%
3 months-2.19%
6 months-29.49%
Current year-32.40%
1 week 8.44
Extreme 8.44
8.65
1 month 8.28
Extreme 8.28
9.65
Current year 7.45
Extreme 7.45
13.55
1 year 7.45
Extreme 7.45
14.57
3 years 7.45
Extreme 7.45
24.11
5 years 7.45
Extreme 7.45
26.09
10 years 5.95
Extreme 5.95
26.09
Manager TitleAgeSince
Director of Finance/CFO - 03/01/2023
President 55 28/09/2023
Corporate Officer/Principal 54 01/06/2007
Director TitleAgeSince
Director/Board Member 74 02/11/2018
Director/Board Member 50 02/11/2018
Director/Board Member 54 02/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.47%-2.53%-40.04%-47.04% 957M
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-1.44%-0.31%+30.21%+37.03% 352B
-3.46%+1.27%+21.99%+40.83% 304B
+0.84%+1.00%+0.94%+11.62% 252B
-1.55%+1.11%+54.15%+75.59% 236B
-0.54%+1.64%-14.34%-56.06% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.92%+1.04%+21.71%+42.09% 367.93B
Weighted average by Cap. -1.13%+0.62%+37.52%+66.75%

Financials

2026 *2027 *
Net sales 5.66B 843M 725M 683M 623M 1.17B 79.59B 1.17B 8.07B 3.13B 40.84B 3.17B 3.1B 132B 6.27B 935M 804M 757M 691M 1.29B 88.23B 1.3B 8.94B 3.47B 45.27B 3.51B 3.43B 146B
Net income 164M 24.37M 20.97M 19.73M 18.02M 33.71M 2.3B 33.81M 233M 90.47M 1.18B 91.51M 89.51M 3.8B 336M 50.02M 43.04M 40.49M 36.99M 69.2M 4.72B 69.39M 479M 186M 2.42B 188M 184M 7.81B
Net Debt - -
Logo KPC Pharmaceuticals,Inc.
KPC Pharmaceuticals Inc is a China-based company primarily engaged in the research, development, manufacturing and sales of pharmaceuticals. The Company operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The Company conducts business in both domestic and overseas markets.
Employees
5,072
Date Price Change Volume
04/09/26 CN¥8.490 +0.47% 3,708,685
03/09/26 CN¥8.450 -0.82% 3,490,700
02/09/26 CN¥8.520 -1.16% 5,557,900
01/09/26 CN¥8.620 +0.58% 4,870,300
31/08/26 CN¥8.570 -1.61% 4,827,400
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.490CNY
Average target price
13.82CNY
Spread / Average Target
+62.78%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600422 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!